0000000000715617

AUTHOR

Lorenzo Nifosì

showing 2 related works from this author

Epulis-Like Presentation of Gingival Renal Cancer Metastasis

2017

Mouth metastatic cancers are very rare and they usually represent the evidence of a widespread disease. Common primary tumors are lung carcinoma in men and breast carcinoma in women, followed by kidney cancer. In the oral soft tissues, the gingiva is the most common site, suggesting a possible role of inflammation in the attraction of circulating tumor cells. Oral metastasis has a serious prognosis. In this work, we describe the case of a 58-year-old man affected by renal cancer, who was brought to our attention for the appearance of a gingival swelling. Initially, the lesion was excised through a provisional clinical diagnosis of epulis. Subsequently, anatomopathological analysis showed a …

OncologyPathologymedicine.medical_specialtyEpulisOphtalmologieCase Reportlcsh:RC254-282MetastasisMetastasis03 medical and health sciences0302 clinical medicineCirculating tumor cellClear-cell adenocarcinomaInternal medicineCarcinomamedicineClear-cell adenocarcinomaRiñones -- CáncerCell proliferationbusiness.industryOral cancerCancerMetástasisKidney cancer030206 dentistryCáncerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseBoca -- CáncerOncology030220 oncology & carcinogenesisbusinessBreast carcinomaKidney cancer
researchProduct

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology

2019

Osteonecrosis of the jaw (ONJ) is a well-known pathological condition in oncology derived from the use of bisphosphonates (BPs) and denosumab. Many molecular and immunological targets have been introduced for daily use in cancer treatment in recent years; consequently, new cases of ONJ have been reported in association with these drugs, especially if administered with BPs and denosumab. When the drugs are administered alone, ONJ is rarely seen. The objective of our study was to analyze the recent literature relative to the association of ONJ with these new drugs highlighting the pathogenic, clinical and therapeutic aspects. The close collaboration between maxillofacial surgeon, oncologist, …

Oncologymedicine.medical_specialtymedicine.medical_treatmentOdontologíaReview ArticleMaxilaresTargeted therapyOncologíaImmunomodulation03 medical and health sciences0302 clinical medicineInternal medicinemedicineOral manifestations030223 otorhinolaryngologyBonePathologicalbusiness.industryGénéralités030206 dentistryImmunotherapyCáncermedicine.diseaseCancer treatmentDenosumabSurgeryOral SurgeryOsteonecrosis of the jawbusinessAngiogenesis modulatorsInfectionmedicine.drug
researchProduct